`
`Filed: October 31, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`NEPTUNE GENERICS, LLC,
`APOTEX INC., APOTEX CORP.,
`TEVA PHARMACEUTICALS USA, INC.,
`and FRESENIUS KABI USA, LLC,
`
`PETITIONERS,
`
`V.
`
`ELI LILLY & COMPANY,
`
`PATENT OWNER.
`
`
`
`___________________
`
`Case IPR2016-002371
`Patent 7,772,209
`___________________
`
`
`
`PETITIONER’S OBJECTIONS TO PATENT OWNER’S SUPPLEMENTAL
`EVIDENCE PURSUANT TO 37 C.F.R. § 42.64(b)(1)
`
`
`1 Cases IPR2016-01190 and IPR2016-01341 have been joined with the instant
`proceeding.
`
`
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioner submits the following
`
`objections to the evidence that Patent Owner first served on October 24, 2016:
`
`Evidence
`Ex. 2125-2128
`
`
`Petitioner’s Objections
`Relevance
`
`The above-listed documents should be excluded because they are not
`
`relevant. See Fed. R. Evid. 401–403. For example, none of Exhibits 2125-2128 are
`
`cited by Patent Owner in its Response (Paper 33). Petitioner reserves its right to
`
`submit additional objections to these exhibits if and when Patent Owner cites or
`
`relies upon them.
`
`Patent Owner also cites testimony from other IPR proceedings not joined
`
`with the present proceeding, as well as other litigation with different prior art at
`
`issue from the present proceeding. See, e.g., Exs. 2125, 2126.
`
`Evidence
`Exs. 2125
`
`The above-listed document should be excluded because it is hearsay and
`
`Petitioner’s Objections
`Hearsay
`
`Patent Owner cannot establish a hearsay exception for admissibility. See
`
`Fed. R. Evid. 801(c)(2).
`
`Evidence
`Exs. 2125
`
`The above-listed document should be excluded because it contains content
`
`Petitioner’s Objections
`Fed. R. Evid. 602, 702-703
`
`
`
`over which the testifier has no personal knowledge, as well as putative expert
`
`
`
`1
`
`
`
`testimony that is unqualified, unreliable, and based on facts or data that experts in
`
`the field would not reasonably rely upon. See Fed. R. Evid. 602, 702-703; Daubert
`
`v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). For example, Exhibit 2125
`
`contains testimony from Clet Niyikiza regarding topics about which he had no
`
`personal knowledge, and for which he is not qualified to testify as an expert.
`
`Evidence
`Ex. 2125
`
`Petitioner’s Objections
`37 C.F.R. § 42.53
`
`The above-listed document should be excluded because it contains trial
`
`testimony that is not submitted in the form of an affidavit and, despite requests to
`
`Patent Owner, an opportunity for cross-examination has thus far been denied. See
`
`37 C.F.R. §§ 42.51(b)(1)(ii), 42.53.
`
`
`
`2
`
`
`
`Respectfully Submitted,
`
`/Sarah E. Spires/
`Sarah E. Spires (Reg. No. 61,501)
`SKIERMONT DERBY LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6601
`Lead Counsel for Petitioner
`
`Dr. Parvathi Kota (Reg. No. 65,122)
`Paul J. Skiermont (pro hac vice
`requested)
`SKIERMONT DERBY LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6621
`
`Mieke K. Malmberg (pro hac vice
`requested)
`SKIERMONT DERBY LLP
`800 Wilshire Boulevard
`Los Angeles, CA 90017
`P: 213-788-4500/F: 213-788-4545
`Back-Up Counsel for Petitioner
`
`
`
`3
`
`October 31, 2016
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Patent Owner a true and correct copy of the foregoing Petitioner’s
`
`Objections to Patent Owner’s Supplemental Evidence Pursuant to 37 C.F.R. §
`
`42.64(b)(1), by electronic means on October 31, 2016 at the following addresses of
`
`record:
`
`Dov P. Grossman (Reg. No. 72,525)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`Direct Phone: 202-434-5812
`Facsimile: 202-434-5029
`dgrossman@wc.com
`Lead Counsel for Patent Owner
`
`Adam L. Perlman (pro hac vice)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`Direct Phone: 202-434-5244
`Facsimile: 202-434-5029
`aperlman@wc.com
`Back-Up Counsel for Patent Owner
`
`John C. Demeter (Reg. No. 30,167)
`ELI LILLY AND COMPANY
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-3785
`Facsimile: 317-276-3861
`demeter_john_c@lilly.com
`Back-Up Counsel for Patent Owner
`
`
`
`
`
`David M. Krinsky (Reg. No. 72,339)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`Direct Phone: 202-434-5338
`Facsimile: 202-480-8302
`dkrinsky@wc.com
`Back-Up Counsel for Patent Owner
`
`James P. Leeds (Reg. No. 35,241)
`ELI LILLY AND COMPANY
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-1667
`Facsimile: 317-277-6534
`leeds_james@lilly.com
`Back-Up Counsel for Patent Owner
`
`John D. Polivick (Reg. No. 57,926)
`RAKOCZY MOLINO
`MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: 312-527-2157
`Fax: 312-527-4205
`jpolivick@rmmslegal.com
`Lead Counsel for Petitioner Apotex
`
`
`
`
`
`Patrick C. Kilgore (Reg. No. 69,131)
`RAKOCZY MOLINO
`MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: 312-527-2157
`Fax: 312-527-4205
`pkilgore@rmmslegal.com
`Back-Up Counsel for Petitioner Apotex
`
`Mark D. Schuman (Reg. No. 31,197)
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST AND SCHUMAN
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Tel: 612-436-9600
`Fax: 612-436-9605
`mschuman@carlsoncaspers.com
`Back-Up Counsel for Petitioner Teva
`
`
`
`Respectfully Submitted,
`
`/Sarah E. Spires/
`Sarah E. Spires (Reg. No. 61,501)
`
`Lead Counsel for Petitioner
`
`
`
`
`
`Deanne M. Mazzochi (Reg. No. 50,158)
`RAKOCZY MOLINO
`MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: 312-527-2157
`Fax: 312-527-4205
`dmazzochi@rmmslegal.com
`Back-Up Counsel for Petitioner Apotex
`
`Gary J. Speier (Reg. No. 45,458)
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST AND SCHUMAN
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Tel: 612-436-9600
`Fax: 612-436-9605
`gspeier@carlsoncaspers.com
`Lead Counsel for Petitioner Teva
`
`Cynthia Lambert Hardman
`(Reg. No. 45,458)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, New York 10018-1405
`Tel: 212-813-8800
`Fax: 212-355-3333
`chardman@goodwinprocter.com
`Back-Up Counsel for Petitioner Teva
`
`Dated: October 31, 2016